Concepedia

Su-Yeon Lee

SL

Statistics

Publications

4

Citations

136

H-Index

4

Active since

2012

Affiliations

Samsung (South Korea)(Current)

Korea Research Institute of Bioscience and Biotechnology

Gachon University

Su-Yeon Lee is an author at Samsung (South Korea) specializing in life sciences, pharmacology, and apoptosis in cancer.

ORCID

Publications per year

2012–2021

4

Publications

4

Adipocyte-Specific Deficiency of De Novo Sphingolipid Biosynthesis Leads to Lipodystrophy and Insulin Resistance

Su-Yeon Lee, Hui‐Young Lee, Jae-Hwi Song et al. · Diabetes · 2017 · 63 citations · Full text

, , +17

Activation of Cannabinoid Receptor Type 1 (Cb1r) Disrupts Hepatic Insulin Receptor Signaling via Cyclic AMP-response Element-binding Protein H (Crebh)-mediated Induction of Lipin1 Gene

Dipanjan Chanda, Yong‐Hoon Kim, Don‐Kyu Kim et al. · Journal of Biological Chemistry · 2012 · 38 citations · Full text

, , +14

Immunogenomic pan-cancer landscape reveals immune escape mechanisms and immunoediting histories

Shinichi Mizuno, Rui Yamaguchi, Takanori Hasegawa et al. · Scientific Reports · 2021 · 19 citations · Full text

, , +17

Regulation of ROS-Dependent JNK Pathway by 2’-Hydroxycinnamaldehyde Inducing Apoptosis in Human Promyelocytic HL-60 Leukemia Cells

Kyung‐Sook Chung, Chae-Bin Yoo, Jeong-Hun Lee et al. · Pharmaceutics · 2021 · 16 citations · Full text

, , +17

1–4 of 4